Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer.

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

[8] Respiratory syncytial virus (RSV) is a highly contagious and potentially serious ... At the heart of this is the company's R&D focus on the science of the immune system, human genetics and ...

QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help ...

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Respiratory Panel Mini test for clinical use. It is the third test to receive ...

human rhinovirus, respiratory syncytial virus (RSV) and SARS-CoV-2. This is more targeted than the comprehensive 21-target QIAstat-Dx Respiratory Panel Plus, which is highly suitable for hospitalized ...

2 Respiratory syncytial virus (RSV) vaccines: Canadian Immunization Guide ... global team driven by Moderna values and mindsets to responsibly change the future of human health, Moderna strives to ...

A viral outbreak in Kolkata is causing dengue-like symptoms including high fever, joint pain, and rashes. Despite extensive testing, few patients are testing positive for dengue or malaria, leading ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of ...